Valuation: FDC Limited

Market Cap 5.23TCr 55Cr 48Cr 44Cr 41Cr 77Cr 78Cr 523.94Cr 205.3Cr 2.61TCr 206.01Cr 201.49Cr 8.62TCr P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 4.71TCr 49Cr 43Cr 40Cr 37Cr 69Cr 71Cr 472.35Cr 185.08Cr 2.35TCr 185.72Cr 181.65Cr 7.77TCr EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-1.26%
1 week-2.01%
Current month-1.26%
1 month-6.82%
3 months+11.03%
6 months+7.39%
Current year-4.36%
1 week 399.05
Extreme 399.05
425.05
1 month 397.05
Extreme 397.05
442
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
527.8
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 01/04/2026
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%-2.01% - - 70Cr
-2.39%-6.24%+47.10%+146.73% 1,02400Cr
-0.76%-3.41%+52.04%+49.73% 62TCr
-2.33%-5.50%+25.55%+64.08% 44TCr
+0.68%+0.25%+38.47%+31.95% 35TCr
-1.66%-1.89%+32.18%+37.17% 30TCr
-8.96%-9.23%+3.57%+3.64% 26TCr
-1.37%-5.71%-2.10%-44.43% 21TCr
-1.63%+0.75%+27.62%+64.43% 21TCr
+0.72%+1.42%+15.88%+73.30% 16TCr
Average -1.27%-1.35%+26.70%+47.40% 39.71TCr
Weighted average by Cap. -0.88%-2.17%+34.56%+69.56%

Financials

2024 2025
Net sales 1.94TCr 20Cr 18Cr 17Cr 15Cr 29Cr 29Cr 194.66Cr 76Cr 968.92Cr 77Cr 75Cr 3.2TCr 2.11TCr 22Cr 19Cr 18Cr 16Cr 31Cr 32Cr 211.21Cr 83Cr 1.05TCr 83Cr 81Cr 3.48TCr
Net income 305.22Cr 3.2Cr 2.78Cr 2.59Cr 2.38Cr 4.5Cr 4.58Cr 31Cr 12Cr 152.21Cr 12Cr 12Cr 503.3Cr 266.79Cr 2.8Cr 2.43Cr 2.27Cr 2.08Cr 3.93Cr 4Cr 27Cr 10Cr 133.04Cr 11Cr 10Cr 439.93Cr
Net Debt -454.93Cr -4.77Cr -4.15Cr -3.87Cr -3.55Cr -6.7Cr -6.82Cr -46Cr -18Cr -226.87Cr -18Cr -18Cr -750.16Cr -514.96Cr -5.4Cr -4.69Cr -4.38Cr -4.02Cr -7.59Cr -7.72Cr -52Cr -20Cr -256.8Cr -20Cr -20Cr -849.15Cr
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
03/26/03 ₹404.65 -1.26% 4,64,734
31/26/31 ₹409.80 +0.58% 1,37,556
30/26/30 ₹407.45 -1.65% 1,02,640
29/26/29 ₹414.30 +1.68% 55,097
28/26/28 ₹407.45 -2.31% 86,917
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B